PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'414090Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, UK.\', \'152809The University of Sheffield Department of Infection Immunity and Cardiovascular Disease, Sheffield, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1177/10760296211066945
?:hasPublicationType
?:journal
  • Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
is ?:pmid of
?:pmid
?:pmid
  • 34905962
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Caution in Using the Activated Partial Thromboplastin Time to Monitor Argatroban in COVID-19 and Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT).
?:type

Metadata

Anon_0  
expand all